Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.

Literature DB >> 19942690

Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.

Filip Van Immerseel¹, Richard Ducatelle¹, Martine De Vos², Nico Boon³, Tom Van De Wiele³, Kristin Verbeke⁴, Paul Rutgeerts⁴, Benedikt Sas⁵, Petra Louis⁶, Harry J Flint⁶.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Butyric Acid

Year: 2009 PMID： 19942690 DOI： 10.1099/jmm.0.017541-0

Source DB: PubMed Journal: J Med Microbiol ISSN： 0022-2615 Impact factor: 2.472

Keyword Cloud
Cited

× No keyword cloud information.

52 in total

Review 1. Probiotics, prebiotics and synbiotics- a review.

Authors: Kavita R Pandey; Suresh R Naik; Babu V Vakil
Journal: J Food Sci Technol Date: 2015-07-22 Impact factor: 2.701

Review 2. Prebiotics metabolism by gut-isolated probiotics.

Authors: Muhamad Hanif Rawi; Siti Aisyah Zaman; Khairul Faizal Pa'ee; Sui Sien Leong; Shahrul Razid Sarbini
Journal: J Food Sci Technol Date: 2020-01-20 Impact factor: 2.701

Review 3. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors: Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal: Therap Adv Gastroenterol Date: 2016-04-19 Impact factor: 4.409

4. Isolation and Characterization of Putative Probiotic Bacterial Strain, Bacillus amyloliquefaciens, from North East Himalayan Soil Based on In Vitro and In Vivo Functional Properties.

Authors: V I Hairul Islam; N Prakash Babu; P Pandikumar; S Ignacimuthu
Journal: Probiotics Antimicrob Proteins Date: 2011-12 Impact factor: 4.609

Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.

Review 1. Probiotics, prebiotics and synbiotics- a review.

Review 2. Prebiotics metabolism by gut-isolated probiotics.

Review 3. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

4. Isolation and Characterization of Putative Probiotic Bacterial Strain, Bacillus amyloliquefaciens, from North East Himalayan Soil Based on In Vitro and In Vivo Functional Properties.

5. Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale.

Review 6. The gut microbiota and Type 1 Diabetes.

7. Butyrate-producing bacteria, including mucin degraders, from the swine intestinal tract.

8. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children.

9. Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease.

Review 10. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.